The Latest Dose

Ep. 24: Reimagining clinical research as new capabilities come to market

Life sciences organizations face intense pressure to speed clinical trials while boosting operational efficiencies to battle the rising costs of drug development. So what does the future of clinical trials look like?

In this episode, Dr. Avi Kulkarni, senior vice president of research and development at Cognizant, and Henry McNamara, senior vice president and GM of Oracle Health Sciences, share their views on what has been accomplished over the past 10 years, current trends, and their outlook for the future.

Podden och tillhörande omslagsbild på den här sidan tillhör oraclehealthsciences. Innehållet i podden är skapat av oraclehealthsciences och inte av, eller tillsammans med, Poddtoppen.